Protea Biosciences Story Overview

PRGB -- USA Stock  

USD 0.04  0.00  0.00%

Macroaxis does not monitor all media channels or aggregates social signals for Protea Biosciences. But even though we do not provide professional-grade financial sentiment analysis on Protea Biosciences, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Protea Biosciences. Additionally take a look at Your Equity Center.
Purchase by Stanley Hostler of 163923 shares of Protea Biosciences
Filed transaction by Protea Biosciences Group director. General open market or private purchase of non-derivative or derivative security

Protea Biosciences Group Inc insider trading alert for perchase of common stock by Stanley Hostler, Vice President and Secretary, on March 8, 2018. This event was filed by Protea Biosciences Group with SEC on 2014-02-13. Statement of changes in beneficial ownership - SEC Form 4. Stanley Hostler is currently serves as vp, secretary, director and member of audit committee of Protea Biosciences G

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for Protea Biosciences

few days ago at www.macroaxis.com 
Purchase by Stephen Turner of 168153 shares of Protea Biosciences
Macroaxis News
Filed transaction by Protea Biosciences Group director. General open market or private purchase of non-derivative or derivative security
over three weeks ago at www.macroaxis.com 
Purchase by Antoline Steve of 73333 shares of Protea Biosciences
Macroaxis News
Filed transaction by Protea Biosciences Group director. General open market or private purchase of non-derivative or derivative security
over three months ago at http://flintdaily.com 
Boussard Gavaudan Investment Management Llp Lifted Alibaba Group Hldg LTD Holding By 59.24 Million ...
news
FlintDaily.comDifficult Not To Win With Alibaba Seeking AlphaFull coverage

Total Asset

Total Asset Comparative Analysis

  Total Asset 
      Protea Biosciences Comparables 
Protea Biosciences is currently under evaluation in total asset category among related companies. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Peers

Protea Biosciences Related Equities

CSLLY  1.58 %   
0%
83.0%
BIIB  1.28 %   
0%
67.0%
NVO  1.10 %   
0%
57.0%
AMGN  0.76 %   
0%
40.0%
VRTX  0.60 %   
0%
31.0%
REGN  0.28 %   
0%
14.0%
GILD  0.11 %   
5.0%
0%
SHPG  0.48 %   
25.0%
0%
CELG  1.83 %   
96.0%
0%
ALXN  1.89 %   
100.0%
0%
Additionally take a look at Your Equity Center. Please also try Price Transformation module to use price transformation models to analyze depth of different equity instruments across global markets.
Search macroaxis.com